C4 Therapeutics Net Tangible Assets

C4 Therapeutics (CCCC) currently reports a net tangible assets of $230M as of March 2026. That compares with $200M in the prior-year period — up 20.0% year over year. Use the charts on this page to explore C4 Therapeutics's net tangible assets history and peer comparisons.

C4 Therapeutics's net tangible assets increased from $200M to $230M — a 20.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

C4 Therapeutics reported $230M in net tangible assets as of March 2026. That compares with $200M in the prior-year period — up 20.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for C4 Therapeutics, and consider following CCCC for alerts when major investors trade the stock.

C4 Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $230M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CCCC with unrelated industries.